28532645|t|Identification of a novel PSEN1 mutation (Leu232Pro) in a Korean patient with early-onset Alzheimer's disease and a family history of dementia
28532645|a|In the present study, a novel mutation in exon 7 of presenilin 1 (Leu232Pro) was discovered in a Korean patient with early-onset Alzheimer's disease, who represented memory decline at 37 years of age, followed by impairment in spatial activity and concentrations and personality changes. Imaging analyses with magnetic resonance scan showed diffuse atrophy in the frontoparietal regions. Targeted next generation sequencing and Sanger sequencing identified a heterozygous T to C transition at position 695 (c.695T>C) of in presenilin 1 gene (PSEN1), resulting in a novel missense mutation at codon 232 from leucine to proline (L232P). Several family members of the patient developed dementia, suggesting an autosomal dominant inheritance; however, we were unable to perform a segregation analysis to confirm this. Since the proline may play a role as a helix breaker, this mutation could significantly disturb the transmembrane helix domain-V of PSEN1 and perturb its protein functions. This hypothesis was supported by the results from the in silico analyses, predicted a major kink on this helix. Several leucine > proline substitutions in other PSEN1 transmembrane helices revealed aggressive AD phenotypes. Future functional studies would be needed to evaluate the pathogenicity of this mutation in AD.
28532645	26	31	PSEN1	T028	C1418985
28532645	32	40	mutation	T045	C0596611
28532645	42	51	Leu232Pro	T087	C0002518
28532645	58	64	Korean	T098	C1556095
28532645	65	72	patient	T101	C0030705
28532645	78	109	early-onset Alzheimer's disease	T047	C0750901
28532645	116	130	family history	T033	C0241889
28532645	134	142	dementia	T048	C0497327
28532645	173	181	mutation	T045	C0596611
28532645	185	191	exon 7	T114,T123	C0015295
28532645	195	207	presenilin 1	T028	C1418985
28532645	209	218	Leu232Pro	T087	C0002518
28532645	224	234	discovered	T052	C1880355
28532645	240	246	Korean	T098	C1556095
28532645	247	254	patient	T101	C0030705
28532645	260	291	early-onset Alzheimer's disease	T047	C0750901
28532645	309	323	memory decline	T048	C0233794
28532645	330	342	years of age	T079	C1510829
28532645	356	366	impairment	T169	C0221099
28532645	370	386	spatial activity	UnknownType	C0814166
28532645	391	405	concentrations	T033	C0235198
28532645	410	429	personality changes	T184	C0240735
28532645	431	447	Imaging analyses	T060	C1881134
28532645	453	476	magnetic resonance scan	T060	C0024485
28532645	492	499	atrophy	T046	C0333641
28532645	507	529	frontoparietal regions	T029	C3496642
28532645	531	566	Targeted next generation sequencing	T063	C2936622
28532645	571	588	Sanger sequencing	T063	C1511897
28532645	602	614	heterozygous	T032	C0019425
28532645	615	648	T to C transition at position 695	T045	C0314627
28532645	650	658	c.695T>C	T045	C0314627
28532645	666	683	presenilin 1 gene	T028	C1418985
28532645	685	690	PSEN1	T028	C1418985
28532645	714	731	missense mutation	T045	C0599155
28532645	735	744	codon 232	T086	C0009221
28532645	750	776	leucine to proline (L232P)	T087	C0002518
28532645	786	800	family members	T099	C0086282
28532645	808	815	patient	T101	C0030705
28532645	826	834	dementia	T048	C0497327
28532645	850	880	autosomal dominant inheritance	T045	C0443147
28532645	919	939	segregation analysis	T062	C0936012
28532645	967	974	proline	T116,T123	C0033382
28532645	996	1001	helix	T082	C1704821
28532645	1002	1009	breaker	T123	C0574031
28532645	1016	1024	mutation	T045	C0596611
28532645	1057	1070	transmembrane	T026	C1167322
28532645	1071	1076	helix	T082	C1704821
28532645	1077	1085	domain-V	T087	C1514562
28532645	1089	1094	PSEN1	T028	C1418985
28532645	1111	1128	protein functions	T044	C1527118
28532645	1135	1145	hypothesis	T078	C1512571
28532645	1187	1202	silico analyses	T062	C0936012
28532645	1222	1226	kink	T169	C0333177
28532645	1235	1240	helix	T082	C1704821
28532645	1250	1257	leucine	T116,T121,T123	C0023401
28532645	1260	1281	proline substitutions	T116,T123	C0033382
28532645	1291	1296	PSEN1	T028	C1418985
28532645	1297	1310	transmembrane	T026	C1167322
28532645	1311	1318	helices	T082	C1704821
28532645	1339	1341	AD	T047	C0750901
28532645	1342	1352	phenotypes	T032	C0031437
28532645	1399	1407	evaluate	T058	C0220825
28532645	1412	1425	pathogenicity	T032	C1136169
28532645	1434	1442	mutation	T045	C0596611
28532645	1446	1448	AD	T047	C0750901